Filing Flows › EBR Systems (EBRCZ) › Recalls, complaints & regulation
EBR Systems (EBRCZ): clinical trials
EBR Systems (EBRCZ) beyond its filings: 4 active clinical trials.
EBR Systems' latest quarter
EBR Systems, Q3 2026: revenue $2.5M (+386% year over year), operating margin -653.3%, net loss $16.6M, operating cash flow −$17.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does EBR Systems have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.